AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 1-25/60
BIOMARKERS IN BENIGN BREAST DISEASE - RISK-FACTORS FOR BREAST-CANCER
Authors: ALLRED DC HILSENBECK SG
Citation: Dc. Allred et Sg. Hilsenbeck, BIOMARKERS IN BENIGN BREAST DISEASE - RISK-FACTORS FOR BREAST-CANCER, Journal of the National Cancer Institute, 90(17), 1998, pp. 1247-1248
IMMUNOFLUORESCENCE MICROSCOPY AND FLOW-CYTOMETRY CHARACTERIZATION OF CHEMICAL INDUCTION OF LATENT EPSTEIN-BARR-VIRUS
Authors: JENSON HB GRANT GM ENCH Y HEARD P THOMAS CA HILSENBECK SG MOYER MP
Citation: Hb. Jenson et al., IMMUNOFLUORESCENCE MICROSCOPY AND FLOW-CYTOMETRY CHARACTERIZATION OF CHEMICAL INDUCTION OF LATENT EPSTEIN-BARR-VIRUS, Clinical and diagnostic laboratory immunology, 5(1), 1998, pp. 91-97
BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO PACLITAXEL, BUTNOT GEMCITABINE, IN MULTIPLE-MYELOMA CELLS
Authors: GAZITT Y ROTHENBERG ML HILSENBECK SG FEY V THOMAS C MONTEGOMREY W
Citation: Y. Gazitt et al., BCL-2 OVEREXPRESSION IS ASSOCIATED WITH RESISTANCE TO PACLITAXEL, BUTNOT GEMCITABINE, IN MULTIPLE-MYELOMA CELLS, International journal of oncology, 13(4), 1998, pp. 839-848
BIOLOGIC CHARACTERISTICS OF SPECIAL-TYPE (ST) COMPARED TO NO-SPECIAL-TYPE (NST) INVASIVE BREAST CANCERS
Authors: LIBBY A HILSENBECK SG ELLEDGE RM ALLRED DC
Citation: A. Libby et al., BIOLOGIC CHARACTERISTICS OF SPECIAL-TYPE (ST) COMPARED TO NO-SPECIAL-TYPE (NST) INVASIVE BREAST CANCERS, Modern pathology, 11(1), 1998, pp. 23-23
RADIATION-THERAPY AND SURVIVAL IN BREAST-CANCER PATIENTS WITH 10 OR MORE POSITIVE AXILLARY LYMPH-NODES TREATED WITH MASTECTOMY
Authors: DIAB SG HILSENBECK SG DEMOOR C CLARK GM OSBORNE CK RAVDIN PM ELLEDGE RM
Citation: Sg. Diab et al., RADIATION-THERAPY AND SURVIVAL IN BREAST-CANCER PATIENTS WITH 10 OR MORE POSITIVE AXILLARY LYMPH-NODES TREATED WITH MASTECTOMY, Journal of clinical oncology, 16(5), 1998, pp. 1655-1660
THE SMALL HEAT-SHOCK-PROTEIN HSP27 INCREASES INVASIVENESS BUT DECREASES MOTILITY OF BREAST-CANCER CELLS
Authors: LEMIEUX P OESTERREICH S LAWRENCE JA STEEG PS HILSENBECK SG HARVEY JM FUQUA SAW
Citation: P. Lemieux et al., THE SMALL HEAT-SHOCK-PROTEIN HSP27 INCREASES INVASIVENESS BUT DECREASES MOTILITY OF BREAST-CANCER CELLS, Invasion & metastasis, 17(3), 1998, pp. 113-123
A PHASE-I AND PHARMACOKINETIC TRIAL OF TEREPHTHALAMIDINE (NSC-57155) AS A 120-HOUR CONTINUOUS-INFUSION
Authors: RODRIGUEZ GI KUHN JG WEISS G DELACRUZ P NEW P FIELDS SM ECKARDT JR CAMPBELL L CLARK GM HILSENBECK SG VONHOFF DD
Citation: Gi. Rodriguez et al., A PHASE-I AND PHARMACOKINETIC TRIAL OF TEREPHTHALAMIDINE (NSC-57155) AS A 120-HOUR CONTINUOUS-INFUSION, Investigational new drugs, 16(1), 1998, pp. 57-67
IGF SYSTEM COMPONENTS AS PROGNOSTIC MARKERS IN BREAST-CANCER
Authors: LEE AV HILSENBECK SG YEE D
Citation: Av. Lee et al., IGF SYSTEM COMPONENTS AS PROGNOSTIC MARKERS IN BREAST-CANCER, Breast cancer research and treatment, 47(3), 1998, pp. 295-302
DIVERSE SIGNALING PATHWAYS MODULATE NUCLEAR RECEPTOR RECRUITMENT OF N-COR AND SMRT COMPLEXES
Authors: LAVINSKY RM JEPSEN K HEINZEL T TORCHIA J MULLEN TM SCHIFF R DELRIO AL RICOTE M NGO S GEMSCH J HILSENBECK SG OSBORNE CK GLASS CK ROSENFELD MG ROSE DW
Citation: Rm. Lavinsky et al., DIVERSE SIGNALING PATHWAYS MODULATE NUCLEAR RECEPTOR RECRUITMENT OF N-COR AND SMRT COMPLEXES, Proceedings of the National Academy of Sciences of the United Statesof America, 95(6), 1998, pp. 2920-2925
BIOLOGIC CHARACTERISTICS OF SPECIAL-TYPE (ST) COMPARED TO NO-SPECIAL-TYPE (NST) INVASIVE BREAST CANCERS
Authors: LIBBY A HILSENBECK SG ELLEDGE RM ALLRED DC
Citation: A. Libby et al., BIOLOGIC CHARACTERISTICS OF SPECIAL-TYPE (ST) COMPARED TO NO-SPECIAL-TYPE (NST) INVASIVE BREAST CANCERS, Laboratory investigation, 78(1), 1998, pp. 113-113
A BIOAVAILABILITY AND PHARMACOKINETIC STUDY OF ORAL AND INTRAVENOUS HYDROXYUREA
Authors: RODRIGUEZ GI KUHN JG WEISS GR HILSENBECK SG ECKARDT JR THURMAN A RINALDI DA HODGES S VONHOFF DD ROWINSKY EK
Citation: Gi. Rodriguez et al., A BIOAVAILABILITY AND PHARMACOKINETIC STUDY OF ORAL AND INTRAVENOUS HYDROXYUREA, Blood, 91(5), 1998, pp. 1533-1541
A RANDOMIZED TRIAL OF CONTINUOUS OR INTERMITTENT THERAPY WITH FLUCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - CLINICALOUTCOMES AND DEVELOPMENT OF FLUCONAZOLE RESISTANCE
Authors: REVANKAR SG KIRKPATRICK WR MCATEE RK FOTHERGILL AW REDDING SW RINALDI MG HILSENBECK SG PATTERSON TF
Citation: Sg. Revankar et al., A RANDOMIZED TRIAL OF CONTINUOUS OR INTERMITTENT THERAPY WITH FLUCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - CLINICALOUTCOMES AND DEVELOPMENT OF FLUCONAZOLE RESISTANCE, The American journal of medicine, 105(1), 1998, pp. 7-11
INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-3 AND INSULIN-RECEPTOR SUBSTRATE-1 IN BREAST-CANCER - CORRELATION WITH CLINICAL-PARAMETERS AND DISEASE-FREE SURVIVAL
Authors: ROCHA RL HILSENBECK SG JACKSON JG VANDENBERG CL WENG CN LEE AV YEE D
Citation: Rl. Rocha et al., INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-3 AND INSULIN-RECEPTOR SUBSTRATE-1 IN BREAST-CANCER - CORRELATION WITH CLINICAL-PARAMETERS AND DISEASE-FREE SURVIVAL, Clinical cancer research, 3(1), 1997, pp. 103-109
PITFALLS IN THE RNA-BASED PCR AMPLIFICATION OF THE CDRIII SEQUENCE FOR QUANTITATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE-MYELOMA (COMMENTARY)
Authors: GAZITT Y HILSENBECK SG
Citation: Y. Gazitt et Sg. Hilsenbeck, PITFALLS IN THE RNA-BASED PCR AMPLIFICATION OF THE CDRIII SEQUENCE FOR QUANTITATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE-MYELOMA (COMMENTARY), Oncology Reports, 4(6), 1997, pp. 1387-1390
POLYETHYLENE-GLYCOL CONJUGATED INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-1 (IGFBP-1) INHIBITS GROWTH OF BREAST-CANCER IN ATHYMIC MICE
Authors: VANDENBERG CL COX GN STROH CA HILSENBECK SG WENG CN MCDERMOTT MJ PRATT D OSBORNE CK CORONADOHEINSOHN EB YEE D
Citation: Cl. Vandenberg et al., POLYETHYLENE-GLYCOL CONJUGATED INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-1 (IGFBP-1) INHIBITS GROWTH OF BREAST-CANCER IN ATHYMIC MICE, European journal of cancer, 33(7), 1997, pp. 1108-1113
PRECLINICAL AND CLINICAL STRATEGIES FOR DEVELOPMENT OF TELOMERASE ANDTELOMERE INHIBITORS
Authors: SHARMA S RAYMOND E SODA H SUN D HILSENBECK SG SHARMA A IZBICKA E WINDLE B VONHOFF DD
Citation: S. Sharma et al., PRECLINICAL AND CLINICAL STRATEGIES FOR DEVELOPMENT OF TELOMERASE ANDTELOMERE INHIBITORS, Annals of oncology, 8(11), 1997, pp. 1063-1074
LACK OF PROGNOSTIC VALUE OF CATHEPSIN-D LEVELS FOR PREDICTING SHORT-TERM OUTCOMES OF BREAST-CANCER PATIENTS
Authors: RAVDIN PM DEMOOR CA HILSENBECK SG SAMOSZUK MK VENDELY PM CLARK GM
Citation: Pm. Ravdin et al., LACK OF PROGNOSTIC VALUE OF CATHEPSIN-D LEVELS FOR PREDICTING SHORT-TERM OUTCOMES OF BREAST-CANCER PATIENTS, Cancer letters, 116(2), 1997, pp. 177-183
INCREASED TUMOR PROLIFERATION AND GENOMIC INSTABILITY WITHOUT DECREASED APOPTOSIS IN MMTV-RAS MICE DEFICIENT IN P53
Authors: HUNDLEY JE KOESTER SK TROYER DA HILSENBECK SG SUBLER MA WINDLE JJ
Citation: Je. Hundley et al., INCREASED TUMOR PROLIFERATION AND GENOMIC INSTABILITY WITHOUT DECREASED APOPTOSIS IN MMTV-RAS MICE DEFICIENT IN P53, Molecular and cellular biology, 17(2), 1997, pp. 723-731
PHASE-II STUDY OF FLUTAMIDE AS 2ND LINE CHEMOTHERAPY IN PATIENTS WITHADVANCED PANCREATIC-CANCER
Authors: SHARMA JJ RAZVILLAS B STEPHENS CD HILSENBECK SG SHARMA A ROTHENBERG ML
Citation: Jj. Sharma et al., PHASE-II STUDY OF FLUTAMIDE AS 2ND LINE CHEMOTHERAPY IN PATIENTS WITHADVANCED PANCREATIC-CANCER, Investigational new drugs, 15(4), 1997, pp. 361-364
WAF1 CIP1 PROTEIN EXPRESSION IN HUMAN BREAST-TUMORS/
Authors: DIAB SG YU YY HILSENBECK SG ALLRED DC ELLEDGE RM
Citation: Sg. Diab et al., WAF1 CIP1 PROTEIN EXPRESSION IN HUMAN BREAST-TUMORS/, Breast cancer research and treatment, 43(2), 1997, pp. 99-103
PROGNOSTIC-SIGNIFICANCE OF PAI-1 AND UPA IN CYTOSOLIC EXTRACTS OBTAINED FROM NODE-POSITIVE BREAST-CANCER PATIENTS
Authors: GRONDAHLHANSEN J HILSENBECK SG CHRISTENSEN IJ CLARK GM OSBORNE CK BRUNNER N
Citation: J. Grondahlhansen et al., PROGNOSTIC-SIGNIFICANCE OF PAI-1 AND UPA IN CYTOSOLIC EXTRACTS OBTAINED FROM NODE-POSITIVE BREAST-CANCER PATIENTS, Breast cancer research and treatment, 43(2), 1997, pp. 153-163
MITOSIN (A NEW PROLIFERATION MARKER) CORRELATES WITH CLINICAL OUTCOMEIN NODE-NEGATIVE BREAST-CANCER
Authors: ALLRED DC CLARK GM HILSENBECK SG OSBORNE CK LEE WH
Citation: Dc. Allred et al., MITOSIN (A NEW PROLIFERATION MARKER) CORRELATES WITH CLINICAL OUTCOMEIN NODE-NEGATIVE BREAST-CANCER, Laboratory investigation, 76(1), 1997, pp. 69-69
CELL TURNOVER (PROLIFERATION AND APOPTOSIS) IN NORMAL EPITHELIUM AND PREMALIGNANT LESIONS IN THE SAME BREAST
Authors: PROSSER J HILSENBECK SG FUQUA SAW OCONNELL P OSBORNE CK ALLRED DC
Citation: J. Prosser et al., CELL TURNOVER (PROLIFERATION AND APOPTOSIS) IN NORMAL EPITHELIUM AND PREMALIGNANT LESIONS IN THE SAME BREAST, Laboratory investigation, 76(1), 1997, pp. 119-119
PREOPERATIVE SPIROMETRY AND LAPAROTOMY - BLOWING AWAY DOLLARS
Authors: DENINO LA LAWRENCE VA AVERYT EC HILSENBECK SG DHANDA R PAGE CP
Citation: La. Denino et al., PREOPERATIVE SPIROMETRY AND LAPAROTOMY - BLOWING AWAY DOLLARS, Chest, 111(6), 1997, pp. 1536-1541
DIFFERENTIAL REGULATION OF CELL-CYCLE CHARACTERISTICS AND APOPTOSIS IN MMTV-MYC AND MMTV-RAS MOUSE MAMMARY-TUMORS
Authors: HUNDLEY JE KOESTER SK TROYER DA HILSENBECK SG BARRINGTON RE WINDLE JJ
Citation: Je. Hundley et al., DIFFERENTIAL REGULATION OF CELL-CYCLE CHARACTERISTICS AND APOPTOSIS IN MMTV-MYC AND MMTV-RAS MOUSE MAMMARY-TUMORS, Cancer research, 57(4), 1997, pp. 600-603
Risultati: 1-25 | 26-50 | 51-60